Abstract:OBJECTIVE:This experiment was designed to study the effect of small molecule tripeptide CMS024 on tumor growth and metastasis in a nude mice model of human hepatocellular carcinoma (HCC) metastasis. METHODS:Highly metastatic human HCC cell strain HCCLM6 was injected into subcutaneous region of nude mice. When the subcutaneous tumor reached 0.8 cm in diameter, the tumor was removed and cut into small pieces about 1 mm in diameter and implanted orthotopically into the liver of 20 BALB/c nude mice, which were randomized into treatment group and control group each with 10 mice. The treatment group received daily CMS024 intraperitoneal injection at the dose of 300 microg/kg beginning from the second postoperative day. The control group received intraperitoneal injection of equal amount of 0.85% sodium chloride solution. The mice were observed for signs of disease development. Thirty-five days later, the mice were sacrificed and abdominal and pulmonary metastases were recorded and peripheral blood hematological and biochemical parameters were determined. RESULTS:After 35 days of intervention, all the 10 mice in the treatment group were alive and well, but there were only 9 living mice in the control group. The mean tumor weights were 1.9 g +/- 0.5 g in the treatment group and 2.3 g +/- 0.8 g in the control group (P > 0.05). The abdominal wall metastases and intraperitoneal metastases were 100% for the control group and only 60% and 50%, respectively, for the treatment group (P < 0.05). Bloody ascites and gross intrahepatic metastatic nodules were found in 70% and 90% of nude mice, respectively, for the control group, and 20% and 40%, respectively, for the treatment group (P > 0.05). The median number of grades I, II, III and IV pulmonary metastases were 92, 24, 15 and 16, respectively, for the control group, and 24, 20, 10 and 8, respectively, for the treatment group. There were statistically significant differences in the number of grade I pulmonary metastases between the treatment group and the control group (24 vs 92, P < 0.05). No statistically significant differences in the body weight, peripheral blood hematological and biochemical parameters were observed between the two groups. No toxic effects were observed during the observation period. CONCLUSIONS:Small molecule tripeptide CMS024 demonstrated positive effects to retard tumor growth and inhibit loco-regional and long distance metastases in a nude mice model of human HCC metastasis, and no obvious toxic or side effects on the tumor bearing nude mice.

Effect of Octreotide on Recurrence and Metastasis of Hepatocellular Carcinoma after Curative Resection in Nude Mice

Effect of Octreotide on Angiogenesis Induced by Hepatocellular Carcinoma in Vivo

Effect of Interferon-Α and All-Trans Retinoic Acid on Recurrence and Metastasis of Hepatocellular Carcinoma

Anti-carcinoma Effect of Targeted Radiotherapy Using 90Y-Dota-octreotide Mediated by Somatostatin Receptor

The Effect of Octreotide on Growth Inhibition of Subcutaneous Implanted Tumor with Human Gallbladder Carcinoma in Nude Mice

Octreotide Acts As an Antitumor Angiogenesis Compound and Suppresses Tumor Growth in Nude Mice Bearing Human Hepatocellular Carcinoma Xenografts.

[Experimental Observation on the Alteration of Metastatic Potential and Its Gene Function Net of Residual Hepatocellular Carcinoma Following Palliative Liver Resection].

Combination gene therapy for tumor recurrence and metastasis of human hepatocellular carcinoma of nude mice model using in vivo imaging

Study on the Inhibitory Effect of Small Tripeptide CMS024 on Tumor Growth and Metastasis in Nude Mice Model of Human Hepatocellular Carcinoma Metastasis

Studies on Postoperative Recurrence and Metastasis of Hepatocellular Carcinoma

Study on the Inhibitory Effect of Tyroserleutide on Tumor Growth and Metastasis in Nude Mice Model of Human Hepatocellular Carcinoma Metastasis

[Changes of Metastatic Potential of Residual Hepatocellular Carcinoma in Nude Mice after in Vivo Chemotherapy and the Corresponding Mechanisms].

Mechanism of Interferon Alpha on Inhibition of Metastasis and Angiogenesis of Hepatocellular Carcinoma after Curative Resection in Nude Mice

Establishment of a High Metastatic Potential Human Hepatocellular Carcinoma Orthotopic Transplantation Model with Palliative Liver Resection in Nude Mice

Establishment of metastatic human hepatocellular carcinoma orthotopic transplantation model with palliative resection for investigating the biological characteristics of residual cancer in nude mice

High-Dose and Long-Term Therapy with Interferon-Alfa Inhibits Tumor Growth and Recurrence in Nude Mice Bearing Human Hepatocellular Carcinoma Xenografts with High Metastatic Potential

The Effects of Oxaliplatin on the Invasion and Metastatic Potential of Orthotopic Hepatocellular Carcinoma Nude Mice Model Established with Fluorescent HepG2 Cells

Metastatic Human Hepatocellular Carcinoma Models in Nude Mice and Cell Line with Metastatic Potential

The Establishment of Metastatic Human Hepatocellular Carcinoma Orthotopic Transplantation Model in Combination with Hepatic Artery Ligation in Nude Mice

Capecitabine Inhibits Postoperative Recurrence and Metastasis after Liver Cancer Resection in Nude Mice with Relation to the Expression of Platelet-Derived Endothelial Cell Growth Factor

Inhibition of the Nude Mice Liver Cancer Metastasis and Recurrence by Beta Peptides